高级检索
当前位置: 首页 > 详情页

Causal relationship between immune cells and risk of myocardial infarction: evidence from a Mendelian randomization study

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Foshan Women & Children Hosp, Cardiol Dept, Geriatr Dept, Foshan, Guangdong, Peoples R China [2]Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Gastroenterol, Kunming, Yunnan, Peoples R China [3]Kunming Univ Sci & Technol, Med Sch, Kunming, Yunnan, Peoples R China [4]Jieyang Third Peoples Hosp, Dept Crit Care Med, Jieyang, Guangdong, Peoples R China [5]Lanzhou Univ, Clin Med Coll 1, Lanzhou, Peoples R China
出处:
ISSN:

关键词: causal inference myocardial infarction genome-wide association study MR analysis immunity

摘要:
Background Atherosclerotic plaque rupture is a major cause of heart attack. Previous studies have shown that immune cells are involved in the development of atherosclerosis, but different immune cells play different roles. The aim of this study was to investigate the causal relationship between immunological traits and myocardial infarction (MI).Methods To assess the causal association of immunological profiles with myocardial infarction based on publicly available genome-wide studies, we used a two-sample mendelian randomization (MR) approach with inverse variance weighted (IVW) as the main analytical method. Sensitivity analyses were used to assess heterogeneity and horizontal pleiotropy.Results A two-sample MR analysis was conducted using IVW as the primary method. At a significance level of 0.001, we identified 47 immunophenotypes that have a significant causal relationship with MI. Seven of these were present in B cells, five in cDC, four in T cells at the maturation stage, six in monocytes, five in myeloid cells, 12 in TBNK cells, and eight in Treg cells. Sensitivity analyses were performed to confirm the robustness of the MR results.Conclusions Our results provide strong evidence that multiple immune cells have a causal effect on the risk of myocardial infarction. This discovery provides a new avenue for the development of therapeutic treatments for myocardial infarction and a new target for drug development.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 心脏和心血管系统
JCR分区:
出版当年[2023]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Foshan Women & Children Hosp, Cardiol Dept, Geriatr Dept, Foshan, Guangdong, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82478 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号